Literature DB >> 33414722

Blood-Brain Barrier Leakage Is Increased in Parkinson's Disease.

Sarah Al-Bachari1,2,3, Josephine H Naish4,5, Geoff J M Parker5,6, Hedley C A Emsley1,2,3, Laura M Parkes3,7.   

Abstract

BACKGROUND: Blood-brain barrier (BBB) disruption has been noted in animal models of Parkinson's disease (PD) and forms the basis of the vascular hypothesis of neurodegeneration, yet clinical studies are lacking.
OBJECTIVE: To determine alterations in BBB integrity in PD, with comparison to cerebrovascular disease.
METHODS: Dynamic contrast enhanced magnetic resonance images were collected from 49 PD patients, 15 control subjects with cerebrovascular disease [control positive (CP)] and 31 healthy control subjects [control negative (CN)], with all groups matched for age. Quantitative maps of the contrast agent transfer coefficient across the BBB (K trans) and plasma volume (v p ) were produced using Patlak analysis. Differences in K trans and v p were assessed with voxel-based analysis as well as in regions associated with PD pathophysiology. In addition, the volume of white matter lesions (WMLs) was obtained from T2-weighted fluid attenuation inversion recovery (FLAIR) images.
RESULTS: Higher K trans, reflecting higher BBB leakage, was found in the PD group than in the CN group using voxel-based analysis; differences were most prominent in the posterior white matter regions. Region of interest analysis confirmed K trans to be significantly higher in PD than in CN, predominantly driven by differences in the substantia nigra, normal-appearing white matter, WML and the posterior cortex. WML volume was significantly higher in PD compared to CN. K trans values and WML volume were similar in PD and CP, suggesting a similar burden of cerebrovascular disease despite lower cardiovascular risk factors.
CONCLUSION: These results show BBB disruption in PD.
Copyright © 2020 Al-Bachari, Naish, Parker, Emsley and Parkes.

Entities:  

Keywords:  Parkinson’s disease; blood–brain barrier; cerebrovascular disease; dynamic contrast enhanced MRI; neurovascular unit

Year:  2020        PMID: 33414722      PMCID: PMC7784911          DOI: 10.3389/fphys.2020.593026

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  68 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

Review 2.  Vascular dysfunction in the pathogenesis of Alzheimer's disease--A review of endothelium-mediated mechanisms and ensuing vicious circles.

Authors:  Luigi Yuri Di Marco; Annalena Venneri; Eszter Farkas; Paul C Evans; Alberto Marzo; Alejandro F Frangi
Journal:  Neurobiol Dis       Date:  2015-08-23       Impact factor: 5.996

3.  Pericytes control key neurovascular functions and neuronal phenotype in the adult brain and during brain aging.

Authors:  Robert D Bell; Ethan A Winkler; Abhay P Sagare; Itender Singh; Barb LaRue; Rashid Deane; Berislav V Zlokovic
Journal:  Neuron       Date:  2010-11-04       Impact factor: 17.173

Review 4.  Small vessel disease: mechanisms and clinical implications.

Authors:  Joanna M Wardlaw; Colin Smith; Martin Dichgans
Journal:  Lancet Neurol       Date:  2019-05-13       Impact factor: 44.182

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 6.  Review: cerebral microvascular pathology in ageing and neurodegeneration.

Authors:  W R Brown; C R Thore
Journal:  Neuropathol Appl Neurobiol       Date:  2011-02       Impact factor: 8.090

7.  Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease.

Authors:  Yin Xia Chao; Bei Ping He; Samuel Sam Wah Tay
Journal:  J Neuroimmunol       Date:  2009-10-09       Impact factor: 3.478

8.  Integrity of normal-appearing white matter: Influence of age, visible lesion burden and hypertension in patients with small-vessel disease.

Authors:  Susana Muñoz Maniega; Francesca M Chappell; Maria C Valdés Hernández; Paul A Armitage; Stephen D Makin; Anna K Heye; Michael J Thrippleton; Eleni Sakka; Kirsten Shuler; Martin S Dennis; Joanna M Wardlaw
Journal:  J Cereb Blood Flow Metab       Date:  2016-07-21       Impact factor: 6.200

9.  Blood-brain barrier breakdown in the aging human hippocampus.

Authors:  Axel Montagne; Samuel R Barnes; Melanie D Sweeney; Matthew R Halliday; Abhay P Sagare; Zhen Zhao; Arthur W Toga; Russell E Jacobs; Collin Y Liu; Lilyana Amezcua; Michael G Harrington; Helena C Chui; Meng Law; Berislav V Zlokovic
Journal:  Neuron       Date:  2015-01-21       Impact factor: 17.173

10.  Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration.

Authors:  Joanna M Wardlaw; Eric E Smith; Geert J Biessels; Charlotte Cordonnier; Franz Fazekas; Richard Frayne; Richard I Lindley; John T O'Brien; Frederik Barkhof; Oscar R Benavente; Sandra E Black; Carol Brayne; Monique Breteler; Hugues Chabriat; Charles Decarli; Frank-Erik de Leeuw; Fergus Doubal; Marco Duering; Nick C Fox; Steven Greenberg; Vladimir Hachinski; Ingo Kilimann; Vincent Mok; Robert van Oostenbrugge; Leonardo Pantoni; Oliver Speck; Blossom C M Stephan; Stefan Teipel; Anand Viswanathan; David Werring; Christopher Chen; Colin Smith; Mark van Buchem; Bo Norrving; Philip B Gorelick; Martin Dichgans
Journal:  Lancet Neurol       Date:  2013-08       Impact factor: 44.182

View more
  18 in total

1.  Blood-brain barrier permeability in response to caffeine challenge.

Authors:  Zixuan Lin; Dengrong Jiang; Peiying Liu; Yulin Ge; Abhay Moghekar; Hanzhang Lu
Journal:  Magn Reson Med       Date:  2022-06-26       Impact factor: 3.737

2.  Blood-brain barrier link to human cognitive impairment and Alzheimer's Disease.

Authors:  Giuseppe Barisano; Axel Montagne; Kassandra Kisler; Julie A Schneider; Joanna M Wardlaw; Berislav V Zlokovic
Journal:  Nat Cardiovasc Res       Date:  2022-02-07

Review 3.  Targeting Macroautophagy as a Therapeutic Opportunity to Treat Parkinson's Disease.

Authors:  Irene Sanchez-Mirasierra; Saurav Ghimire; Sergio Hernandez-Diaz; Sandra-Fausia Soukup
Journal:  Front Cell Dev Biol       Date:  2022-07-06

4.  The XPO1 Inhibitor KPT-8602 Ameliorates Parkinson's Disease by Inhibiting the NF-κB/NLRP3 Pathway.

Authors:  Shuhan Liu; Shengxiang Wang; Runze Gu; Na Che; Jing Wang; Jinbo Cheng; Zengqiang Yuan; Yong Cheng; Yajin Liao
Journal:  Front Pharmacol       Date:  2022-06-01       Impact factor: 5.988

Review 5.  Emerging Roles for Aberrant Astrocytic Calcium Signals in Parkinson's Disease.

Authors:  Eric A Bancroft; Rahul Srinivasan
Journal:  Front Physiol       Date:  2022-01-11       Impact factor: 4.566

6.  Reduced Immunosenescence of Peripheral Blood T Cells in Parkinson's Disease with CMV Infection Background.

Authors:  Julia D Vavilova; Anna A Boyko; Natalya V Ponomareva; Vitaly F Fokin; Ekaterina Y Fedotova; Maria A Streltsova; Sofya A Kust; Maria V Grechikhina; Ekaterina V Bril; Olga S Zimnyakova; Elena I Kovalenko; Alexander M Sapozhnikov
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

7.  A Multimodal MR Imaging Study of the Effect of Hippocampal Damage on Affective and Cognitive Functions in a Rat Model of Chronic Exposure to a Plateau Environment.

Authors:  Dongyong Zhu; Bo He; Mengdi Zhang; Yixuan Wan; Ruibin Liu; Lei Wang; Yi Zhang; Yunqing Li; Fabao Gao
Journal:  Neurochem Res       Date:  2022-01-04       Impact factor: 3.996

Review 8.  Microvascular Changes in Parkinson's Disease- Focus on the Neurovascular Unit.

Authors:  Gesine Paul; Osama F Elabi
Journal:  Front Aging Neurosci       Date:  2022-03-10       Impact factor: 5.750

Review 9.  The Link between Gut Dysbiosis Caused by a High-Fat Diet and Hearing Loss.

Authors:  Dagmara Kociszewska; Jeffrey Chan; Peter R Thorne; Srdjan M Vlajkovic
Journal:  Int J Mol Sci       Date:  2021-12-07       Impact factor: 5.923

Review 10.  Basal lamina changes in neurodegenerative disorders.

Authors:  Benjamin Nguyen; Gregory Bix; Yao Yao
Journal:  Mol Neurodegener       Date:  2021-12-07       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.